Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence # †
Open Access
- 1 May 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 49 (Suppl. 5) , S85-S95
Abstract
We systematically reviewed the literature on the extent to which population characteristics or clinical features predict groups of individuals likely to develop advanced liver disease or die from chronic infection with hepatitis B virus (HBV). We searched Medline to include studies with reported cirrhosis, liver failure, liver cancer, or death outcomes after at least 1 year of follow-up from the measurement of predictive factors (age, age at infection, geographic location, race/ethnicity, sex, positive family history, presence of coinfections, HBV viral level, change in hepatitis B e antigen [HBeAg] status, genotype, HBV mutations, nonalcoholic fatty liver disease, alcohol consumption, liver enzymes, and liver biopsy finding). Evidence from 41 included articles suggested that cirrhosis, higher HBV viral level, and male sex were consistently associated with significantly increased risk of death and liver cancer. Evidence about the role of HBV genotype, HBeAg status, age and duration of infection, coinfections with hepatitis C virus, human immunodeficiency virus, hepatitis delta virus, and alanine aminotransferase levels were limited and inconsistent, but were deemed promising to identify patients at higher risk of clinical outcomes. Adults with chronic hepatitis B had increased risk for poorer health outcomes compared to the general population; however, the magnitude of risk varied greatly depending on baseline patient and disease characteristics, and typically clinical outcomes required many years to become manifest. Many adults with chronic hepatitis B had low absolute risks of clinical outcomes and likely would not benefit from immediate treatment. Baseline patient and disease characteristics provide important information about the risk of clinical outcomes and should be incorporated into monitoring or treatment decisions. (Hepatology 2009;49:S85–S95.)Keywords
This publication has 38 references indexed in Scilit:
- High Viral Load and Hepatitis B Virus Subgenotype Ce Are Associated With Increased Risk of Hepatocellular CarcinomaJournal of Clinical Oncology, 2008
- Cancer incidence in people with hepatitis B or C infection: A large community-based linkage studyJournal of Hepatology, 2006
- Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA LevelJAMA, 2006
- Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinomaWorld Journal of Gastroenterology, 2006
- Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort studyInternational Journal of Epidemiology, 2004
- The Natural History of Hepatitis D Virus Infection in Illinois State Facilities for The Developmentally DisabledAmerican Journal of Gastroenterology, 2001
- Prospective Study of Hepatitis B and C Viral Infections, Cigarette Smoking, Alcohol Consumption, and Other Factors Associated with Hepatocellular Carcinoma Risk in JapanAmerican Journal of Epidemiology, 2000
- Hepatitis B and C Virus Serologies among Japanese Americans with Hepatocellular CarcinomaThe Journal of Infectious Diseases, 1996
- Survival in Chronic Hepatitis BAnnals of Internal Medicine, 1984
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUSThe Lancet, 1981